| Overview |
| bsm-90076r-50µL |
| ATP2A2 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human SERCA2 |
| 1001-1042/1042 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 488 |
| P16615 |
| ATP2A2; ATPase Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transporting 2; SERCA2; Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2; Calcium Pump 2; ATP2B; Endoplasmic Reticulum Class 1/2 Ca(2+) ATPase; SR Ca(2+)-ATPase; DAR; Calcium-Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform; ATPase Ca++ Transporting Cardiac Muscle Slow Twitch 2; ATPase Ca++ Transporting Cardiac Muscle Slow Twitch 2; ATPase Ca++ Dependent Slow-Twitch Cardiac Muscle-2; Cardiac Ca2+ ATPase; EC 7.2.2.10; EC 3.6.3.8; EC 3.6.3; DD |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |